Teladoc Health, Inc.

NYSE:TDOC

Medical - Healthcare Information Services

Healthcare
$8.06 +2.57%

+$0.20 today

Market cap
$1.47B
Beta
2.14
P/E (TTM)
-8.1
EPS (TTM)
-$0.96
52W Low $4.40High $9.77

Volume 3.96M

Average 4.68M

TDOC Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

Teladoc Health, Inc.NYSE: TDOC

Net Receivables · Q1 FY2026 · quarter ended Mar 2026

Net receivables falls 8.5% from a year ago

Net receivables stood at $222.54M at the end of Q1 FY2026, down 8.5% from a year earlier and up 10.4% from the prior quarter. Over 3 fiscal years it compounded at -5.1% a year.

Context

  • Net receivables amounted to 7.9% of total assets at the end of Q1 FY2026, up 0.9 pp from a year earlier.
  • Net receivables increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps falling in the next quarterly balance sheet after a -8.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$222.54M+10.4% QoQ
Last fiscal yearDec 2025
$201.66M-10.0% YoY
Year agoMar 2025
$243.23M-8.5% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-8.5%——
1 year-10.0%——
3-year CAGR-5.1%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
201.66M USD
Year-over-year change
-10.0%
4-year CAGR
+1.5%

Net Receivables vs competitors

How TDOC compares with its peers on the latest reported figures

  • Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -8.5% is the 6th highest of 10, against a peer median of -5.3%.
  • Net receivables amounts to 7.9% of total assets for TDOC, versus a peer median of 11.0%.
TDOC Competitors
Net Receivables for TDOC and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
OMCLOmnicell, Inc.Mar 2026$264.21M USD+5.0%-10.2%13.2%
PGNYProgyny, Inc.Jun 2026$257.48M USD-5.3%-2.8%36.0%
TDOCTeladoc Health, Inc.Mar 2026$222.54M USD-8.5%-5.1%7.9%
EVOEvotec SEMar 2026€167.23M EUR-38.8%-8.2%10.2%
AZTAAzenta, Inc.Sep 2026$143.42M USD-24.2%-0.5%8.4%
PHRPhreesia, Inc.Apr 2026$143.31M USD+32.6%+44.4%21.5%
NVCRNovoCure LimitedMar 2026$93.27M USD-21.3%+2.8%11.8%
SDGRSchrödinger, Inc.Sep 2026$48.36M USD-15.7%+14.7%7.9%
OMDAOmada HealthMar 2026$39.99M USD+36.6%+43.7%13.2%
PHVSPharvaris N.V.Sep 2026€5.98M EUR+103.7%+128.3%2.0%
IMNMImmunome, Inc.Sep 2026$0 USD——0.0%
Peer median (excluding TDOC) —-5.3%+2.8%11.0%

Competitors are the stored peer set for TDOC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents893.48M918.18M1.12B1.3B781.08M
Short-term Investments2.54M0000
Net Receivables190.12M235.65M230.06M223.96M201.66M
Inventory73.08M56.34M29.51M38.14M38.2M
Other Current Assets27.96M12.1M40.15M36.02M2.07M
Total Current Assets1.23B1.29B1.49B1.66B1.09B
Property, Plant & Equipment (Net)74.01M71.47M72.09M56.58M53.09M
Goodwill14.5B1.07B1.07B283.19M283.19M
Intangible Assets1.91B1.84B1.68B1.43B1.3B
Long-term Investments00000
Tax Assets0355.6M00242.5M
Other Non-current Assets20.7M78.5M80.26M81.49M137.62M
Total Non-current Assets16.51B3.42B2.9B1.85B2.01B
Total Assets17.73B4.7B4.39B3.52B3.1B
Account Payables47.26M47.69M43.64M33.13M47.97M
Short-term Debt013.59M0550.72M11.04M
Tax Payables13.06M3.82M13.55M28.11M0
Deferred Revenue75.57M101.83M95.66M79.3M62.31M
Other Current Liabilities132.21M151.28M167.26M108.69M187.17M
Total Current Liabilities331.01M399.77M420.62M941.54M404.74M
Long-term Debt1.23B1.54B1.54B991.42M994.92M
Deferred Tax Liabilities75.78M406.54M49.45M49.85M271.44M
Deferred Revenue (Non-current)3.83M11.95M13.62M9.79M9.14M
Other Non-current Liabilities10.78M1.62M1.08M720K643K
Total Non-current Liabilities1.36B1.99B1.65B1.08B1.31B
Total Liabilities1.69B2.39B2.07B2.03B1.72B
Common Stock160K163K167K173K178K
Retained Earnings(1.42B)(15.01B)(15.23B)(16.23B)(16.43B)
Accumulated OCI(6.29M)(42.78M)(36.99M)(38.39M)(34.73M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity16.05B2.31B2.33B1.49B1.39B
Total Debt1.28B1.59B1.59B1.58B1.04B
Net Debt386.65M668.74M468.6M286.29M259.08M

Teladoc Health, Inc.

NYSE:TDOC

Intrinsic Alpha fair value

Locked

Current Price

$8.06

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.